BEL AIR, Md. and SAN FRANCISCO, May 14, 2024 /PRNewswire/ -- Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858.